176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.04%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
11.76%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
13.92%
EBIT growth below 50% of TSM's 106.81%. Michael Burry would suspect deeper competitive or cost structure issues.
13.92%
Operating income growth under 50% of TSM's 106.81%. Michael Burry would be concerned about deeper cost or sales issues.
14.32%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
27.78%
EPS growth at 50-75% of TSM's 40.00%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
8.33%
Diluted EPS growth under 50% of TSM's 40.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-14.98%
Share reduction while TSM is at 12.72%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
3.01%
Diluted share reduction more than 1.5x TSM's 12.72%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
2.58%
OCF growth of 2.58% while TSM is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
175.14%
FCF growth of 175.14% while TSM is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
537.74%
10Y revenue/share CAGR above 1.5x TSM's 175.35%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
537.74%
5Y revenue/share CAGR above 1.5x TSM's 140.88%. David Dodd would look for consistent product or market expansions fueling outperformance.
537.74%
Positive 3Y CAGR while TSM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
1014.35%
OCF/share CAGR of 1014.35% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1014.35%
OCF/share CAGR of 1014.35% while TSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
1014.35%
3Y OCF/share CAGR of 1014.35% while TSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
926.41%
Positive 10Y CAGR while TSM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
926.41%
Positive 5Y CAGR while TSM is negative. John Neff might view this as a strong mid-term relative advantage.
926.41%
Positive short-term CAGR while TSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
779.74%
Equity/share CAGR of 779.74% while TSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
779.74%
Equity/share CAGR of 779.74% while TSM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
779.74%
Equity/share CAGR of 779.74% while TSM is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.77%
AR growth is negative/stable vs. TSM's 8.10%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
18.73%
We show growth while TSM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.42%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
33.76%
Positive BV/share change while TSM is negative. John Neff sees a clear edge over a competitor losing equity.
-0.28%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
17.89%
R&D dropping or stable vs. TSM's 29511.76%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
10.81%
SG&A declining or stable vs. TSM's 36937.03%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.